Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action
- PMID: 112630
- DOI: 10.1007/BF00429689
Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action
Abstract
Amitriptyline and zimelidine significantly reduce the uptake of 5-HT into the blood platelets of depressive patients. The degree of inhibition is significantly correlated with the plasma drug level of amitriptyline. No significant relationship could be detected between the degree of inhibition of uptake and therapeutic outcome. The accepted mode of action of tricyclic antidepressant drugs and the deficiency hypotheses of affective disorders are discussed.
Similar articles
-
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs. 1982 Sep;24(3):169-206. doi: 10.2165/00003495-198224030-00001. Drugs. 1982. PMID: 6215240 Review.
-
Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.Br J Clin Pharmacol. 1979 Oct;8(4):375-8. doi: 10.1111/j.1365-2125.1979.tb04725.x. Br J Clin Pharmacol. 1979. PMID: 508514 Free PMC article. Clinical Trial. No abstract available.
-
The action of antidepressant drugs on 5-hydroxy-tryptamine uptake by platelets--relationship to therapeutic effect.Acta Psychiatr Scand Suppl. 1981;290:236-43. doi: 10.1111/j.1600-0447.1981.tb00725.x. Acta Psychiatr Scand Suppl. 1981. PMID: 6939313
-
Zimelidine: a therapeutic and pharmacokinetic study in depression.Psychopharmacology (Berl). 1979 Jun 21;63(3):199-202. doi: 10.1007/BF00433549. Psychopharmacology (Berl). 1979. PMID: 113803 Clinical Trial.
-
Antidepressants and the serotonin uptake in platelets.Acta Psychiatr Scand Suppl. 1980;280:111-9. Acta Psychiatr Scand Suppl. 1980. PMID: 6996427 Review. No abstract available.
Cited by
-
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs. 1982 Sep;24(3):169-206. doi: 10.2165/00003495-198224030-00001. Drugs. 1982. PMID: 6215240 Review.
-
Biological classification of depressive illness.Br J Clin Pharmacol. 1983;15 Suppl 2(Suppl 2):161S-164S. doi: 10.1111/j.1365-2125.1983.tb05861.x. Br J Clin Pharmacol. 1983. PMID: 6402001 Free PMC article.
-
Proceedings of the British Pharmacological Society. 10th-12th September, 1980. Abstracts.Br J Pharmacol. 1981 Mar;72(3):487P-590P. doi: 10.1111/j.1476-5381.1981.tb11001.x. Br J Pharmacol. 1981. PMID: 7260488 Free PMC article. No abstract available.
-
Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.Br J Clin Pharmacol. 1983;15 Suppl 3(Suppl 3):365S-368S. doi: 10.1111/j.1365-2125.1983.tb02127.x. Br J Clin Pharmacol. 1983. PMID: 6407498 Free PMC article.
-
Alaproclate--an open clinical study in depressive illness.Psychopharmacology (Berl). 1984;83(3):285-7. doi: 10.1007/BF00464796. Psychopharmacology (Berl). 1984. PMID: 6433393
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources